Post E - Search Results

1

PEGylation improves pharmacokinetic profile, liver uptake and efficacy of Interferon gamma in liver fibrosis.

Bansal R, Post E, Proost JH, de Jager-Krikken A, Poelstra K, Prakash J. Bansal R, et al. Among authors: post e. J Control Release. 2011 Sep 25;154(3):233-40. doi: 10.1016/j.jconrel.2011.05.027. Epub 2011 Jun 12. J Control Release. 2011. PMID: 21664391

2

Albumin-binding and tumor vasculature determine the antitumor effect of 15-deoxy-Delta-(12,14)-prostaglandin-J(2) in vivo.

Prakash J, Bansal R, Post E, de Jager-Krikken A, Lub-de Hooge MN, Poelstra K. Prakash J, et al. Among authors: post e. Neoplasia. 2009 Dec;11(12):1348-58. doi: 10.1593/neo.91188. Neoplasia. 2009. PMID: 20019843 Free PMC article.

3

A novel approach to deliver anticancer drugs to key cell types in tumors using a PDGF receptor-binding cyclic peptide containing carrier.

Prakash J, de Jong E, Post E, Gouw AS, Beljaars L, Poelstra K. Prakash J, et al. Among authors: post e. J Control Release. 2010 Jul 14;145(2):91-101. doi: 10.1016/j.jconrel.2010.03.018. Epub 2010 Mar 31. J Control Release. 2010. PMID: 20362019

4

Reduction of fibrogenesis by selective delivery of a Rho kinase inhibitor to hepatic stellate cells in mice.

van Beuge MM, Prakash J, Lacombe M, Gosens R, Post E, Reker-Smit C, Beljaars L, Poelstra K. van Beuge MM, et al. Among authors: post e. J Pharmacol Exp Ther. 2011 Jun;337(3):628-35. doi: 10.1124/jpet.111.179143. Epub 2011 Mar 7. J Pharmacol Exp Ther. 2011. PMID: 21383021

5

Increased liver uptake and reduced hepatic stellate cell activation with a cell-specific conjugate of the Rho-kinase inhibitor Y27632.

van Beuge MM, Prakash J, Lacombe M, Post E, Reker-Smit C, Beljaars L, Poelstra K. van Beuge MM, et al. Among authors: post e. Pharm Res. 2011 Aug;28(8):2045-54. doi: 10.1007/s11095-011-0430-9. Epub 2011 Mar 26. Pharm Res. 2011. PMID: 21442374 Free PMC article.

6

Targeting tumor stromal cells through a PDGF-beta receptor binding carrier.

Prakash J, de Jong E, Post E, Mohammad AK, Beljaars L, Poelstra K. Prakash J, et al. Among authors: post e. J Control Release. 2010 Nov 20;148(1):e116. doi: 10.1016/j.jconrel.2010.07.088. J Control Release. 2010. PMID: 21529587 No abstract available.

7

Novel engineered targeted interferon-gamma blocks hepatic fibrogenesis in mice.

Bansal R, Prakash J, Post E, Beljaars L, Schuppan D, Poelstra K. Bansal R, et al. Among authors: post e. Hepatology. 2011 Aug;54(2):586-96. doi: 10.1002/hep.24395. Epub 2011 Jun 26. Hepatology. 2011. PMID: 21538439

8

Enhanced effectivity of an ALK5-inhibitor after cell-specific delivery to hepatic stellate cells in mice with liver injury.

van Beuge MM, Prakash J, Lacombe M, Post E, Reker-Smit C, Beljaars L, Poelstra K. van Beuge MM, et al. Among authors: post e. PLoS One. 2013;8(2):e56442. doi: 10.1371/journal.pone.0056442. Epub 2013 Feb 18. PLoS One. 2013. PMID: 23441194 Free PMC article.

9

Selective delivery of IFN-γ to renal interstitial myofibroblasts: a novel strategy for the treatment of renal fibrosis.

Poosti F, Bansal R, Yazdani S, Prakash J, Post E, Klok P, van den Born J, de Borst MH, van Goor H, Poelstra K, Hillebrands JL. Poosti F, et al. Among authors: post e. FASEB J. 2015 Mar;29(3):1029-42. doi: 10.1096/fj.14-258459. Epub 2014 Dec 2. FASEB J. 2015. PMID: 25466892

10

PGE2-treated macrophages inhibit development of allergic lung inflammation in mice.

Draijer C, Boorsma CE, Reker-Smit C, Post E, Poelstra K, Melgert BN. Draijer C, et al. Among authors: post e. J Leukoc Biol. 2016 Jul;100(1):95-102. doi: 10.1189/jlb.3MAB1115-505R. Epub 2016 Mar 1. J Leukoc Biol. 2016. PMID: 26931576 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

431 results

Search Page

Filters